Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implications of incorporating morbidity into primary care workload models for NHS funding allocations: a retrospective observational study in England.

BMJ open·2026
Same author

Exploring Patient Perspectives on the Use of Artificial Intelligence to Inform Joint Decision-Making for Patients With Multiple Conditions in Primary Care in the United Kingdom: Qualitative Study.

Journal of medical Internet research·2026
Same author

Maternal Health of Female Sex Workers in Six Low- and Middle-Income Countries.

International journal of women's health·2026
Same author

Perspectives on caregiver-reported outcomes in cardiovascular diseases today and in future healthcare services: a statement of Association of Cardiovascular Nursing & Allied Professions (ACNAP), Association for Acute CardioVascular Care (ACVC), the Heart Failure Association (HFA), ESC Council on Stroke, and Global Heart Hub, the International Alliance of Heart Patient Organisations.

European journal of cardiovascular nursing·2026
Same author

Deaths of Female Sex Workers from HIV/AIDS in Kenya, Nigeria, and the Democratic Republic of the Congo 2019-2023 and Barriers to Antiretroviral Therapy Adherence.

International journal of environmental research and public health·2026
Same author

Causes of death among young children of female sex workers in three sub-Saharan African countries: a cross-sectional exploratory investigation.

Frontiers in public health·2026
Same journal

Flexible Survival Extrapolation with Blended Hazards: Accounting for Treatment Effect Waning in Health Technology Assessment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes-Chronic Kidney Disease Model.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Taste or Scale? Methodological Approach to Health Preferences Comparison across Groups.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Mind the Gap: Impact of New Labels on Public Perceptions and Calculated Risk of Adverse Outcomes after a Melanoma In Situ Diagnosis-A Secondary Analysis of an Online Randomized Experiment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Metamodel-Based General-Purpose Autocalibration Tool for Simulation Models.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

The Dutch Implantable Cardioverter-Defibrillator Decision Aid in Clinical Practice: A Stepped-Wedge Randomized Controlled Trial.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
See all related articles

Related Experiment Videos

Cardiovascular Risk Estimation and Statin Adherence: A Historical Cohort Study.

Samuel Finnikin1, Brian Willis1, Tim Evans2

  • 1Department of Applied Health Sciences College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Medical Decision Making : an International Journal of the Society for Medical Decision Making
|June 15, 2026
PubMed
Summary
This summary is machine-generated.

Utilizing cardiovascular disease (CVD) risk scores during statin initiation improves patient adherence and persistence with medication. This practice is linked to significant reductions in CVD and all-cause mortality, highlighting the importance of shared decision-making.

Keywords:
Hydroxymethylglutaryl-CoA reductase inhibitorscardiovascular diseasemedication adherenceshared decision making

Related Experiment Videos

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Statin adherence for cardiovascular disease (CVD) primary prevention is suboptimal.
  • Shared decision-making (SDM) may enhance statin adherence.
  • CVD risk estimation is crucial for SDM in statin initiation.

Purpose of the Study:

  • To investigate the association between CVD risk score presence at statin initiation and subsequent statin adherence and persistence.
  • To explore the relationship between CVD risk scoring and CVD outcomes and mortality.

Main Methods:

  • A cohort of 255,730 statin-naïve patients aged 40-84 initiating statins for primary prevention (2017-2020) was analyzed.
  • Patients were categorized by the presence or absence of a CVD risk score at initiation.
  • Multivariable modeling assessed associations with adherence, persistence, CVD outcomes, and death.

Main Results:

  • The presence of a CVD risk score was observed in 67.7% of patients.
  • CVD risk scoring was associated with a 7% increase in statin adherence and an 8% reduction in discontinuations.
  • A 15% reduction in CVD and all-cause mortality was observed in patients with a CVD risk score.

Conclusions:

  • CVD risk scoring at statin initiation is linked to improved adherence and persistence, suggesting enhanced SDM quality.
  • CVD risk scoring demonstrated a significant reduction in CVD and mortality, exceeding that explained by adherence alone.
  • Integrating CVD risk scores and SDM into statin initiation consultations may improve patient outcomes.